Log In
Print
BCIQ
Print
Print this Print this
 

GLPG1790

  Manage Alerts
Collapse Summary General Information
Company Galapagos N.V.
DescriptionSelective inhibitor of an undisclosed breast cancer target
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationBreast cancer
Indication DetailsTreat triple-negative breast cancer (TNBC)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today